---
title: How LLM-Generated Health IT Code Affects Downstream Clinical Safety
description: 'Three pathways through which LLM-generated health IT code affects downstream clinical safety: direct coding errors, data handling failures, and regulatory non-compliance.'
author: pi
editor: lam
date: 2026-06-19T23:09:39.292Z
tags:
  - LLM
  - healthcare
  - software-engineering
  - code-generation
  - AI-safety
  - healthcare-IT
  - risk
  - security
  - regulatory
---

The intersection of LLM-generated code and clinical safety creates a compounding risk profile that existing research has only begun to map. Three distinct pathways connect LLM-generated health IT code to downstream patient harm.

**Pathway 1: Direct coding errors in clinical logic.** When LLMs generate code for clinical algorithms — drug dosage calculators, lab value interpreters, risk stratification scores — errors in the generated logic can directly cause incorrect clinical decisions. The risk is amplified because: (a) LLM-generated code has documented vulnerability rates of 40% across 18 vulnerability types, including logic errors, injection flaws, and improper resource handling; (b) clinical code often handles edge cases (rare drug interactions, paediatric dosing, organ failure adjustments) that are underrepresented in training data; (c) the apparent plausibility of LLM-generated clinical code reduces reviewer vigilance (@terragni2025; @navneet2025). A sepsis prediction model that led to delayed interventions despite insufficient accuracy is a documented real-world failure of AI-generated clinical logic (@choudhury2024).

**Pathway 2: Data handling and privacy failures in generated code.** LLMs trained on public code repositories reproduce common security anti-patterns in generated health IT code: hardcoded credentials, improper access controls, insecure data serialisation, and missing input validation. These become critical when the code handles protected health information (PHI). Even when the LLM's clinical output is correct, the infrastructure code it generates (FHIR API endpoints, EHR integration modules, database access layers) may introduce data breach vectors. With HIPAA penalties of $50,000-$1.5M per violation category per year, a single security defect in LLM-generated health IT code carries existential financial risk for healthcare organisations (@terragni2025; @weissman2024).

**Pathway 3: Regulatory non-compliance embedded in generated artifacts.** LLMs cannot reliably self-constrain to produce FDA-compliant medical software artifacts. Weissman et al. (2024) demonstrated that even when prompted with FDA CDS device criteria, GPT-4 produced devicelike clinical decision support output in 100% of time-critical emergency scenarios. This non-compliance extends to generated code: when LLMs generate FHIR implementation code, EHR integration modules, or clinical decision support logic, they may produce artifacts that would require FDA pre-market clearance but lack the design control documentation, hazard analysis, and verification traceability required by 21 CFR Part 820 and ISO 13485. The generated code itself may implement clinical functions that, under FDA guidance, would classify the software as a medical device — but without the accompanying quality system that makes such classification safe (@weissman2024).

**Compounding effect.** The true risk lies at the intersection of all three pathways: an LLM generates the clinical logic code (pathway 1) with data handling flaws (pathway 2) that also implements unregulated CDS functionality (pathway 3). This compounding is uniquely dangerous because each pathway individually is addressable, but their combination in a single generated artifact can evade both engineering code review (reviewers focus on clinical logic, miss security flaws) and clinical validation (reviewers focus on output accuracy, miss regulatory non-compliance).

**Evaluation gap.** Only 5% of LLM evaluation studies in healthcare use real patient care data. The vast majority (95%) focus exclusively on accuracy metrics while neglecting fairness (15.8%), deployment readiness (4.6%), and calibration (1.2%). No study in the literature systematically evaluates the safety of LLM-generated health IT code in clinical deployment context (@knott2026). This represents a critical blind spot in the evidence base.